Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Doğan Yazılıtaş"'
Autor:
Muhammed Kızılgül, Ömer Bayır, Bekir Uçan, Pınar Akhanlı, Hakan Düğer, Muhammed Erkam Sencar, Hayri Kertmen, Demet Yılmazer, Doğan Yazılıtaş, Güleser Saylam, Mehmet Hakan Korkmaz, Erman Çakal
Publikováno v:
Einstein (São Paulo), Vol 21 (2023)
ABSTRACT In this article, we present a case of diffuse follicular variant papillary thyroid carcinoma with pituitary metastasis, which is a rare cause of pituitary metastasis. The follicular variant of papillary thyroid carcinoma is an uncommon varia
Externí odkaz:
https://doaj.org/article/e7ab7ade98cd468ea09926d504788bc6
Autor:
Onur Ergun, Erdem Birgi, Azad Hekimoğlu, Önder Eraslan, Hasan Ali Durmaz, Cengiz Karaçin, Gökşen İnanç İmamoğlu, Tülay Eren, Doğan Yazılıtaş, Baki Hekimoğlu
Publikováno v:
Acta Radiologica. :028418512311756
Background In recent years, many studies have proven that percutaneous thermal ablation is an effective second-line treatment method with low complication rates in early-stage non-small cell lung carcinoma and lung metastases. Radiofrequency ablation
Autor:
Deniz Tural, Terry L. Ng, Noemi Reguart, Ömer Fatih Ölmez, Ozgur Ozyilkan, Ahmet Sezer, Ilhan Oztop, Mehmet Ali Kaplan, Laila C. Roisman, E. Filippova, Irfan Cicin, Aziz Karaoglu, Umut Demirci, Petros Christopoulos, Elizabeth Dudnik, Fatma Buğdaycı Başal, Perran Fulden Yumuk, D.R. Camidge, Sergei V. Orlov, Mehmet Ali Nahit Sendur, Nezih Meydan, Saadettin Kilickap, Mustafa Erman, Oliver Gautschi, Havva Yesil Cinkir, Patrizia Froesch, Kerem Okutur, Ismail Beypinar, Nir Peled, Kübra Aydın, Devrim Cabuk, Julien Mazieres, Hasan Şenol Coşkun, Alisan Zirtiloglu, Hande Turna, Taner Korkmaz, Abdurrahman Isikdogan, Roni Gillis, Ahmet Demirkazik, R. Grinberg, Doğan Yazılıtaş, Cengiz Yilmaz, Adnan Aydiner, Yesim Eralp, Semra Paydas, Filiz Çay Şenler, Ibrahim Yildiz, Moiseenko Fedor
Publikováno v:
Web of Science
Lorlatinib is a third-generation tyrosine-kinases inhibitor (TKI) targeting ALK/ROS1 fusions. the FDA has approved lorlatinib for TKI-pretreated ALK(+) NSCLC, while its approval for ROS1( + ) is still pending. Here we present the largest real-world d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa5766b0b6f75e47142bb5ab9ba635fc
https://hdl.handle.net/11454/61883
https://hdl.handle.net/11454/61883
Autor:
Sema Turker, Hayriye Sahinli, Perihan Perkin, Dogan Yazilitas, Nimet Oge Koklu, Goksen Inanc Imamoglu, Cengiz Karacin, Mustafa Altinbas
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 3, Pp 147-148 (2018)
We present a patient with uncommon metastases of lung cancer. The patient has been followed-up for early stage laryngeal carcinoma in the remission and has had dyspeptic complaints as well. A 62-year-old male patient had epigastric complaints for thr
Externí odkaz:
https://doaj.org/article/177ba3bf3527431189e21bc699c36794